Successful Treatment of Erythrodermic Mycosis Fungoides with Mogamulizumab Followed by Etoposide Monotherapy

Mogamulizumab induces cytotoxicity against CCR4+ lymphoma cells by antibody-dependent cell-mediated cytotoxicity in advanced cutaneous T-cell lymphoma patients. Since the efficacy of mogamulizumab in mycosis fungoides (28.6%) is lower than that in Sézary syndrome (47.1%), reagents that enhance the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujimura, Taku, Tanita, Kayo, Sato, Yota, Kambayashi, Yumi, Furudate, Sadanori, Tsukada, Akira, Hashimoto, Akira, Aiba, Setsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836287/
https://www.ncbi.nlm.nih.gov/pubmed/29515406
http://dx.doi.org/10.1159/000486278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836287/
https://www.ncbi.nlm.nih.gov/pubmed/29515406
http://dx.doi.org/10.1159/000486278

Ejemplares similares